Localization of key medical isotope products significantly reduces cancer treatment costs

Recently, China Nuclear Group was informed that the first batch of domestically produced by china Nuclear Power Research and Design Institute of the first batch of domestic ally-89 nuclide officially delivered to Chengdu Nuclear Qualcomm Isotope Co., Ltd., which means that China has successfully opened up research and development, reactor operation, irradiation, product production of the whole process of key technologies in this field, to solve the medical isotopes rely heavily on imports, formally has the capacity of chlorinated radon supply, both for domestic patients to significantly reduce treatment costs, but also to further make a better domestic production industrycancer bone metastasis is one of the common complications of malignant tumors, about 65%-80% of the advanced malignant tumors will occur bone metastasis, of which, the highest incidence of bone pain, seriously affecting the daily activities of patients, self-care ability, communication ability and overall quality of life, related comprehensive treatment costs are higherradionuclide seropathic therapy is mainly used in patients with widespread bone metastasis cancer, has more than 50 years of history, can specifically kill bone metastasis tumor cells, play a lasting analgesic effectThe chlorpyrifos injection is a radioactive drug that is effective and lowly toxic in treating bone metastasis in prostate and breast cancerThe drug tantalum-89 raw materials before completely dependent on foreign imports, domestic demand for radon-89 50 curie, market supply is unstable, seriously subject to peoplein the overall planning and support of China Nuclear Group, China's chlorpyrifos products ten years grinding a sword, successfully opened up the product research and development and production of the key technology of the whole process, for the next stage of medical isotope research and development and industrialization development has established a strong confidenceit is understood that China's large quantities of medical isotopes are all dependent on imports, although iodine-131 and other small number of isotopes to achieve localization, but can not meet the domestic medical market demandIn order to realize the localization of the production of medical isotopes, as an important force in the research and development of domestic medical isotopes, the nuclear power institute makes full use of the abundant material sesame resources to carry out the research and development of medical isotope production technology in China with new technology and new technologyThis realization of the supply of radon-89, is the nuclear power institute in recent years after the resumption of isotope research and development of the first nuclear technology application development fund support projectssource: Science daily